Therapeutic vaccines based on recombinant pox virus vectors: Phase I Update

Therion Biologics Corp., Cambridge, Mass.
Product: Therapeutic vaccines based

Read the full 90 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE